ANI Pharmaceuticals IncANIP

Capital at risk.

About ANI Pharmaceuticals Inc
Ticker
info
ANIP
Trading on
info
NASDAQ
ISIN
info
US00182C1036
Industry
info
Drug Manufacturers - Specialty & Generic
Sector
info
Healthcare
CEO
info
Nikhil Lalwani
Headquarters
info
210 Main Street West, Baudette, MN, United States, 56623
Employees
info
897
Website
info
anipharmaceuticals.com
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. It markets, sells, and distributes its products through wholesalers, retail market chains, distributors and specialty pharmacies, group purchasing organizations, specialty pharmacies, hospitals, clinics, and physicians. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Metrics
BasicAdvanced
Market cap
info
$1.46B
P/E ratio
info
-
EPS
info
-$1.04
Dividend Yield
info
0.00%
Beta
info
0.63
Forward P/E ratio
info
10.68
EBIDTA
info
$82.3M
Ex dividend date
info
-
Price & volume
Market cap
info
$1.46B
Average daily volume
info
0.4M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
10.68
PEG ratio
info
1.06
Trailing P/E
info
0
Price to sales
info
2.38
Price to book
info
3.58
Earnings
EPS
info
-$1.04
EPS estimate (current quarter)
info
$0.29
EPS estimate (next quarter)
info
$0.14
EBITDA
info
$82.3M
Revenues (TTM)
info
$614M
Revenues per share (TTM)
info
$31.80
Technicals
Beta
info
0.63
52-week High
info
$70.05
52-week Low
info
$52.50
50-day moving average
info
$59.69
200-day moving average
info
$59.54
Short ratio
info
8.01
Short %
info
15.20%
Management effectiveness
ROE (TTM)
info
4.18%
ROA (TTM)
info
0.84%
Profit margin
info
3.02%
Gross profit margin
info
$364M
Operating margin
info
0.80%
Growth
Quarterly earnings growth (YoY)
info
1,382.40%
Quarterly revenue growth (YoY)
info
44.80%
Share stats
Outstanding Shares
info
21.8M
Float
info
15.6M
Insiders %
info
11.22%
Institutions %
info
97.41%
Analyst Insights & forecasts
info

84% Buy

16% Hold

0% Sell

Based on information from 6 analysts.

Average price target

info
$81.50
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
$1.21
$1.00
21.00%
Q1 • 24Beat
$1.02
$0.95
7.37%
Q2 • 24Beat
$1.34
$1.09
22.94%
Q3 • 24Beat
-$0.55
$0.29
287.52%
Q4 • 24Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$148M
$-24.2M
16.29%
Q3 • 24
$191M
$-10.3M
5.39%
Q4 • 24
28.48%
57.48%
66.90%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$1.29B
$857M
66.54%
Q3 • 24
$1.28B
$855M
66.62%
Q4 • 24
0.29%
0.16%
0.12%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$12.5M
$-399M
$291M
$7M
Q3 • 24
$15.9M
$-10.7M
$-4.9M
$13.4M
Q4 • 24
27.14%
97.32%
101.69%
90.30%
QoQ growth
QuarterlyAnnual
Sentiment analysis

-1.5

Extreme greed

+1.5

1.00

Last 30 days

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a ANI Pharmaceuticals Inc share?
Collapse

ANI Pharmaceuticals Inc shares are currently traded for undefined per share.

How many shares does ANI Pharmaceuticals Inc have?
Collapse

ANI Pharmaceuticals Inc currently has 21.8M shares.

Does ANI Pharmaceuticals Inc pay dividends?
Collapse

No, ANI Pharmaceuticals Inc doesn't pay dividends.

What is ANI Pharmaceuticals Inc 52 week high?
Collapse

ANI Pharmaceuticals Inc 52 week high is $70.05.

What is ANI Pharmaceuticals Inc 52 week low?
Collapse

ANI Pharmaceuticals Inc 52 week low is $52.50.

What is the 200-day moving average of ANI Pharmaceuticals Inc?
Collapse

ANI Pharmaceuticals Inc 200-day moving average is $59.54.

Who is ANI Pharmaceuticals Inc CEO?
Collapse

The CEO of ANI Pharmaceuticals Inc is Nikhil Lalwani.

How many employees ANI Pharmaceuticals Inc has?
Collapse

ANI Pharmaceuticals Inc has 897 employees.

What is the market cap of ANI Pharmaceuticals Inc?
Collapse

The market cap of ANI Pharmaceuticals Inc is $1.46B.

What is the P/E of ANI Pharmaceuticals Inc?
Collapse

The current P/E of ANI Pharmaceuticals Inc is null.

What is the EPS of ANI Pharmaceuticals Inc?
Collapse

The EPS of ANI Pharmaceuticals Inc is -$1.04.

What is the PEG Ratio of ANI Pharmaceuticals Inc?
Collapse

The PEG Ratio of ANI Pharmaceuticals Inc is 1.06.

What do analysts say about ANI Pharmaceuticals Inc?
Collapse

According to the analysts ANI Pharmaceuticals Inc is considered a buy.